Nexpoint Asset Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Nexpoint Asset Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-720,851	Closed	-$14.4M	–	172
2022 Q3	$14.4M	Buy	+720,851	New	+$9.51M	0.96%	32

Nexpoint Asset Management's FMTX Position: Q4 2022 in Review

Nexpoint Asset Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 720,851 shares — an estimated $14.4M sold.

Nexpoint Asset Management first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $14.4M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Nexpoint Asset Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Nexpoint Asset Management sold 720,851 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $14.4M.
Nexpoint Asset Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Nexpoint Asset Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $14.4M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Nexpoint Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.